STAGE IV BREAST CANCER

Clinical trials for STAGE IV BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new STAGE IV BREAST CANCER trials appear

Sign up with your email to follow new studies for STAGE IV BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 5 Completed 5 Terminated 1

Could an extra antibody slow HER2+ breast cancer spread?

Disease control Terminated

This trial investigates whether adding bevacizumab (Avastin) to standard first-line chemotherapy plus trastuzumab (Herceptin) helps people with HER2-positive metastatic breast cancer. Participants receive either bevacizumab or a placebo alongside their regular treatment. The main…

Matched conditions: STAGE IV BREAST CANCER

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

STAGE IV BREAST CANCER

Get alerted when new STAGE IV BREAST CANCER trials appear

Could an extra antibody slow HER2+ breast cancer spread?